Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

European Prevention of Alzheimer’s Dementia Longitudinal Cohort Study (EPAD LCS): study protocol
Alina Solomon, Miia Kivipelto, José Luís Molinuevo, et al.
BMJ Open (2018) Vol. 8, Iss. 12, pp. e021017-e021017
Open Access | Times Cited: 91

Showing 1-25 of 91 citing articles:

Donanemab in Early Alzheimer’s Disease
Mark A. Mintun, Albert Lo, Cynthia Evans, et al.
New England Journal of Medicine (2021) Vol. 384, Iss. 18, pp. 1691-1704
Open Access | Times Cited: 1057
Hormone replacement therapy is associated with improved cognition and larger brain volumes in at-risk APOE4 women: results from the European Prevention of Alzheimer’s Disease (EPAD) cohort
Rasha N.M. Saleh, Michael Hornberger, Craig Ritchie, et al.
Alzheimer s Research & Therapy (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 89
Early-stage Alzheimer disease: getting trial-ready
Paul Aisen, Gustavo Jimenez‐Maggiora, Michael S. Rafii, et al.
Nature Reviews Neurology (2022) Vol. 18, Iss. 7, pp. 389-399
Open Access | Times Cited: 87
The Evolution of Master Protocol Clinical Trial Designs: A Systematic Literature Review
Elias Laurin Meyer, Peter Mesenbrink, Cornelia Dunger‐Baldauf, et al.
Clinical Therapeutics (2020) Vol. 42, Iss. 7, pp. 1330-1360
Open Access | Times Cited: 101
Selecting the most important self-assessed features for predicting conversion to mild cognitive impairment with random forest and permutation-based methods
Jaime Gómez‐Ramírez, Marina Ávila‐Villanueva, Miguel A. Fernández‐Blázquez
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 86
Adaptive Platform Trials to Transform Amyotrophic Lateral Sclerosis Therapy Development
Sabrina Paganoni, James Berry, Melanie Quintana, et al.
Annals of Neurology (2021) Vol. 91, Iss. 2, pp. 165-175
Open Access | Times Cited: 67
Application of the ATN classification scheme in a population without dementia: Findings from the EPAD cohort
Silvia Ingala, Casper de Boer, Larissa A Masselink, et al.
Alzheimer s & Dementia (2021) Vol. 17, Iss. 7, pp. 1189-1204
Open Access | Times Cited: 62
The Bayesian Time Machine: Accounting for temporal drift in multi-arm platform trials
Benjamin R. Saville, Donald A. Berry, Nicholas Berry, et al.
Clinical Trials (2022) Vol. 19, Iss. 5, pp. 490-501
Closed Access | Times Cited: 42
Biological brain age prediction using machine learning on structural neuroimaging data: Multi-cohort validation against biomarkers of Alzheimer’s disease and neurodegeneration stratified by sex
Irene Cumplido‐Mayoral, Marina García‐Prat, Grégory Operto, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 35
Diagnostic Performance of Cortical Lesions and the Central Vein Sign in Multiple Sclerosis
Alessandro Cagol, Rosa Cortese, Muhamed Baraković, et al.
JAMA Neurology (2023) Vol. 81, Iss. 2, pp. 143-143
Open Access | Times Cited: 28
Dutch Brain Research Registry for study participant recruitment: Design and first results
Marissa D. Zwan, Wiesje M. van der Flier, Solange Cleutjens, et al.
Alzheimer s & Dementia Translational Research & Clinical Interventions (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 45
Brain Health Services: organization, structure, and challenges for implementation. A user manual for Brain Health Services—part 1 of 6
Daniele Altomare, José Luís Molinuevo, Craig Ritchie, et al.
Alzheimer s Research & Therapy (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 45
The PREVENT dementia programme: baseline demographic, lifestyle, imaging and cognitive data from a midlife cohort study investigating risk factors for dementia
Craig Ritchie, Katie Bridgeman, Sarah Gregory, et al.
Brain Communications (2024) Vol. 6, Iss. 3
Open Access | Times Cited: 8
Randomised trials conducted using cohorts: a scoping review
Beverley Jane Nickolls, Clare Relton, Lars G. Hemkens, et al.
BMJ Open (2024) Vol. 14, Iss. 3, pp. e075601-e075601
Open Access | Times Cited: 7
Trial Participation in Neurodegenerative Diseases: Barriers and Facilitators
Daphne N. Weemering, Anita Beelen, Tessa Kliest, et al.
Neurology (2024) Vol. 103, Iss. 1
Open Access | Times Cited: 6
THE EUROPEAN PREVENTION OF ALZHEIMER’S DEMENTIA (EPAD) LONGITUDINAL COHORT STUDY: BASELINE DATA RELEASE V500.0
C.W. Ritchie, Graciela Muñiz‐Terrera, Miia Kivipelto, et al.
The Journal of Prevention of Alzheimer s Disease (2019), pp. 1-7
Open Access | Times Cited: 52
Cross-sectional and longitudinal association of sleep and Alzheimer biomarkers in cognitively unimpaired adults
Jonathan Blackman, Laura Stankeviciute, Eider M. Arenaza‐Urquijo, et al.
Brain Communications (2022) Vol. 4, Iss. 6
Open Access | Times Cited: 28
Progression models for repeated measures: Estimating novel treatment effects in progressive diseases
Lars Lau Rakêt
Statistics in Medicine (2022) Vol. 41, Iss. 28, pp. 5537-5557
Open Access | Times Cited: 25
Eigenvector centrality dynamics are related to Alzheimer’s disease pathological changes in non-demented individuals
Luigi Lorenzini, Silvia Ingala, Lyduine E. Collij, et al.
Brain Communications (2023) Vol. 5, Iss. 3
Open Access | Times Cited: 16
Alzheimer's disease genetic pathways impact cerebrospinal fluid biomarkers and imaging endophenotypes in non‐demented individuals
Luigi Lorenzini, Lyduine E. Collij, Niccoló Tesi, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 9, pp. 6146-6160
Open Access | Times Cited: 5
Evaluating the Alzheimer's disease data landscape
Colin Birkenbihl, Yasamin Salimi, Daniel Domingo‐Fernándéz, et al.
Alzheimer s & Dementia Translational Research & Clinical Interventions (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 37
The Open-Access European Prevention of Alzheimer’s Dementia (EPAD) MRI dataset and processing workflow
Luigi Lorenzini, Silvia Ingala, Alle Meije Wink, et al.
NeuroImage Clinical (2022) Vol. 35, pp. 103106-103106
Open Access | Times Cited: 20
Interactions between apolipoprotein E, sex, and amyloid-beta on cerebrospinal fluid p-tau levels in the European prevention of Alzheimer's dementia longitudinal cohort study (EPAD LCS)
Tyler S. Saunders, Natalie Jenkins, Kaj Blennow, et al.
EBioMedicine (2022) Vol. 83, pp. 104241-104241
Open Access | Times Cited: 20
Regional associations of white matter hyperintensities and early cortical amyloid pathology
Luigi Lorenzini, Loes T Ansems, Isadora Lopes Alves, et al.
Brain Communications (2022) Vol. 4, Iss. 3
Open Access | Times Cited: 19
Modifiable dementia risk factors and AT(N) biomarkers: findings from the EPAD cohort
Eddy Roccati, Aidan Bindoff, Jessica M. Collins, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top